drugset / Trial / NCT04080076

Comparative and Efficacy Study of ACTHar Gel Alone or in Combination With Tacrolimus in Fibrillary Glomerulopathy

NCT04080076

RandomizedSingle-groupOpen-labelTreatment

Summary

Treatment with combination ACTHar gel and Tacrolimus therapy or ACTHar gel therapy alone in lowering urinary protein to creatinine (UP/Cr) ratios

Timeline

Start
2019-01-12
Primary completion
2024-09-06
Completion
2024-09-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acthar Peptide 80 iu Subcutaneous
Comparator Tacrolimus Small molecule 1 mg Oral

Indications